Inhibition of the chemokine receptors CXCR1 and CXCR2 synergizes with docetaxel for effective tumor control and remodeling of the immune microenvironment of HPV-negative head and neck cancer models

Abstract Background Relapsed head and neck squamous cell carcinoma (HNSCC) unrelated to HPV infection carries a poor prognosis. Novel approaches are needed to improve the clinical outcome and prolong survival in this patient population which has poor long-term responses to immune checkpoint blockade...

Descripció completa

Dades bibliogràfiques

Autors principals:	Lucas A. Horn, Hanne Lind, Kristen Fousek, Haiyan Qin, Nika Rajabian, Shantel Angstadt, Nicole Hsiao-Sanchez, Miriam M. Medina-Enriquez, Marcus D. Kelly, Clint T. Allen, Sarah M. Hammoudeh, Roberto Weigert, Dean Y. Maeda, John A. Zebala, Claudia Palena
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2024-12-01
Col·lecció:	Journal of Experimental & Clinical Cancer Research
Matèries:	HNSCC CXCR1 CXCR2 IL-8 Docetaxel Immunotherapy
Accés en línia:	https://doi.org/10.1186/s13046-024-03240-3
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!